Gaps in Adherence to Guideline-Directed Medical Therapy Before Defibrillator Implantation.
作者信息
Fonarow Gregg C, Ziaeian Boback
机构信息
Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles Medical Center, Los Angeles, California.
Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, California; Department of Health Policy and Management, Fielding School of Public Health at UCLA, Los Angeles, California.
出版信息
J Am Coll Cardiol. 2016 Mar 8;67(9):1070-1073. doi: 10.1016/j.jacc.2015.12.045.
Abstract
摘要
相似文献
1
Gaps in Adherence to Guideline-Directed Medical Therapy Before Defibrillator Implantation.植入除颤器前遵循指南指导的药物治疗方面的差距。
J Am Coll Cardiol. 2016 Mar 8;67(9):1070-1073. doi: 10.1016/j.jacc.2015.12.045.
2
Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation.在植入心脏复律除颤器之前使用指南指导的心力衰竭药物治疗。
J Am Coll Cardiol. 2016 Mar 8;67(9):1062-1069. doi: 10.1016/j.jacc.2015.12.046.
3
Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008.2006 年至 2008 年期间，国家心血管数据注册中心接受心脏再同步治疗除颤器植入术的患者中，指南指导的药物治疗的流行率。
Am J Cardiol. 2014 Jun 15;113(12):2052-6. doi: 10.1016/j.amjcard.2014.03.049. Epub 2014 Apr 1.
4
Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications.是否低估了心力衰竭指南的依从性？治疗禁忌的影响。
Am Heart J. 2012 Nov;164(5):750-755.e1. doi: 10.1016/j.ahj.2012.08.002. Epub 2012 Oct 16.
5
Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry.接受植入式心脏复律除颤器治疗的患者中最佳药物治疗的应用：来自国家心血管数据注册库的见解。
Arch Intern Med. 2012 Jan 9;172(1):64-7. doi: 10.1001/archinternmed.2011.466. Epub 2011 Nov 14.
6
Guideline-Directed Medical Therapy Before and After Primary Prevention Implantable Cardioverter Defibrillator Implantation in New Zealand (ANZACS-QI 66).新西兰初级预防植入式心脏除颤器植入前后指南导向的药物治疗（ANZACS-QI 66）。
Heart Lung Circ. 2022 Nov;31(11):1531-1538. doi: 10.1016/j.hlc.2022.06.691. Epub 2022 Aug 20.
7
Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.心力衰竭患者植入式心脏复律除颤器使用情况的医院差异及特征：来自“遵循指南-心力衰竭”（GWTG-HF）注册研究的数据
J Am Coll Cardiol. 2009 Feb 3;53(5):416-22. doi: 10.1016/j.jacc.2008.09.045.
8
Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.比较心力衰竭和射血分数降低的门诊心脏病学患者在有无器械治疗的情况下的药物治疗剂量：来自 IMPROVE HF 的报告。
Circ Heart Fail. 2010 Sep;3(5):596-605. doi: 10.1161/CIRCHEARTFAILURE.109.912683. Epub 2010 Jul 15.
9
Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction.评估近期射血分数降低的心力衰竭退伍军人的护理质量。
JAMA Cardiol. 2022 Feb 1;7(2):130-139. doi: 10.1001/jamacardio.2021.4585.
10
Neurohormonal Antagonists Are Preferred to an Implantable Cardioverter-Defibrillator in Preventing Sudden Death in Heart Failure.在预防心力衰竭猝死方面，神经激素拮抗剂优于植入式心脏复律除颤器。
JACC Heart Fail. 2019 Oct;7(10):902-906. doi: 10.1016/j.jchf.2019.05.013. Epub 2019 Sep 11.
引用本文的文献
1
Disparities in diagnosis and outcomes in American patients with transthyretin cardiac amyloidosis.美国转甲状腺素蛋白心脏淀粉样变性患者在诊断和治疗结果方面的差异。
Int J Cardiovasc Imaging. 2025 Jun 5. doi: 10.1007/s10554-025-03436-4.
2
Evaluation of a Machine Learning-Guided Strategy for Elevated Lipoprotein(a) Screening in Health Systems.卫生系统中基于机器学习的脂蛋白(a)升高筛查策略评估
Circ Genom Precis Med. 2025 Feb;18(1):e004632. doi: 10.1161/CIRCGEN.124.004632. Epub 2025 Jan 23.
3
Analysis of Physician Compliance with Guideline-Directed Medical Therapy for Patients with Heart Failure with Reduced Ejection Fraction: A Real-World Study.射血分数降低的心力衰竭患者医生遵循指南指导药物治疗的分析：一项真实世界研究
Rev Cardiovasc Med. 2023 Sep 18;24(9):257. doi: 10.31083/j.rcm2409257. eCollection 2023 Sep.
4
Team based collaborative care model, facilitated by mHealth enabled and trained nurses, for management of heart failure with reduced ejection fraction in India (TIME-HF): design and rationale of a parallel group, open label, multi-centric cluster randomised controlled trial.基于团队的协作护理模式，由具备移动健康技能并经过培训的护士推动，用于印度射血分数降低的心力衰竭管理（TIME-HF）：一项平行组、开放标签、多中心整群随机对照试验的设计与原理
Wellcome Open Res. 2023 Jul 12;8:197. doi: 10.12688/wellcomeopenres.19196.2. eCollection 2023.
5
The design of the Dashboard Activated Services and Telehealth for Heart Failure (DASH-HF) study: A pragmatic quality improvement randomized implementation trial for patients with heart failure with reduced ejection fraction.Dashboard 激活服务和心力衰竭远程医疗（DASH-HF）研究的设计：一项针对射血分数降低的心力衰竭患者的实用质量改进随机实施试验。
Contemp Clin Trials. 2022 Sep;120:106895. doi: 10.1016/j.cct.2022.106895. Epub 2022 Aug 24.
6
Guideline-directed medical therapy in heart failure patients: impact of focused care provided by a heart failure clinic in comparison to general cardiology out-patient department.心力衰竭患者的指南导向性药物治疗：与普通心脏病门诊相比，心力衰竭诊所提供的针对性护理的影响。
Egypt Heart J. 2020 Aug 24;72(1):53. doi: 10.1186/s43044-020-00088-8.
7
Evaluation of a guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction.射血分数降低的心力衰竭患者指南指导下的药物治疗滴定方案评估
Int J Cardiol Heart Vasc. 2018 Nov 8;22:1-5. doi: 10.1016/j.ijcha.2018.10.003. eCollection 2019 Mar.
本文引用的文献
1
Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation.在植入心脏复律除颤器之前使用指南指导的心力衰竭药物治疗。
J Am Coll Cardiol. 2016 Mar 8;67(9):1062-1069. doi: 10.1016/j.jacc.2015.12.046.
2
Medication Adherence Based on Part D Claims for Patients With Heart Failure After Hospitalization (from the Atherosclerosis Risk in Communities Study).基于医疗保险D部分索赔数据的心力衰竭患者住院后用药依从性（来自社区动脉粥样硬化风险研究）
Am J Cardiol. 2015 Aug 1;116(3):413-9. doi: 10.1016/j.amjcard.2015.04.058. Epub 2015 May 8.
3
Electronic medication packaging devices and medication adherence: a systematic review.电子药物包装设备与药物依从性：一项系统综述
JAMA. 2014 Sep 24;312(12):1237-47. doi: 10.1001/jama.2014.10059.
4
The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.心力衰竭住院患者的全球健康和经济负担：从心力衰竭住院登记中吸取的经验教训。
J Am Coll Cardiol. 2014 Apr 1;63(12):1123-1133. doi: 10.1016/j.jacc.2013.11.053. Epub 2014 Feb 5.
5
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会基金会/美国心脏协会实践指南工作组关于心力衰竭管理的指南：美国心脏病学会基金会/美国心脏协会报告
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239. doi: 10.1016/j.jacc.2013.05.019. Epub 2013 Jun 5.
6
Variation in medication adherence in heart failure.心力衰竭患者药物依从性的差异。
JAMA Intern Med. 2013 Mar 25;173(6):468-70. doi: 10.1001/jamainternmed.2013.2509.
7
Medicare Part D enrollees' use of out-of-plan discounted generic drugs.医疗保险D部分参保人对非计划内折扣通用药物的使用情况。
J Am Geriatr Soc. 2012 Feb;60(2):387-8. doi: 10.1111/j.1532-5415.2011.03812.x.
8
How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?".特发性扩张型心肌病患者符合“SCD-HeFT 标准”时，如何通过优化治疗避免不必要的植入式心脏复律除颤器植入？
Am J Cardiol. 2012 Mar 1;109(5):729-35. doi: 10.1016/j.amjcard.2011.10.033. Epub 2011 Dec 15.
9
Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry.接受植入式心脏复律除颤器治疗的患者中最佳药物治疗的应用：来自国家心血管数据注册库的见解。
Arch Intern Med. 2012 Jan 9;172(1):64-7. doi: 10.1001/archinternmed.2011.466. Epub 2011 Nov 14.
10
Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study.近期扩张型心肌病结局的临床和人口统计学预测因素：IMAC（心肌炎和急性心肌病-2 研究）的结果。
J Am Coll Cardiol. 2011 Sep 6;58(11):1112-8. doi: 10.1016/j.jacc.2011.05.033.
Zotero 插件